New research shows that a harmless strain of Klebsiella – discovered by chance in laboratory experiments – can eliminate infections and reduce gut inflammation in inflammatory bowel disease (IBD).
From volcanic activity to the deaths of millions: Using climate data and documentary evidence, researchers have painted a detailed picture of how the Black Death pandemic reached Europe.
Microplastics pose a human health risk in more ways than one, a new study reveals: not only do the particles harbor pathogenic bacteria, they may also help the spread of antimicrobial resistance.
Pseudomonas aeruginosa, a hospital-acquired bacterium that causes serious infections, can move from the lungs to the gut inside the same patient, raising the risk of sepsis, new research reveals.
A team of researchers comprehensively catalogued a new collection of bacteria-eating viruses called phages. These phages could be used to combat Klebsiella pneumoniae - a serious threat in hospitals.
An innovative Group A Streptococcus “One-Step Antigen Extraction + Detection” Kit (immunochromatography), developed by GenSure Biotech Inc., has successfully obtained both Class B and Class C EU IVDR certifications for in vitro diagnostic medical devices.
Researchers have discovered a previously unknown mechanism that explains how bacteria within a tumor can drive treatment resistance in patients with oral and colorectal cancer.
Scientists are on the way to finding a vaccine to fight off Helicobacter pylori - a bacterium found in over 60% of people - possibly preventing stomach ulcers and lowering the risk for stomach cancer.
When the many protect the few: An expert explains the premise of herd immunity, and how vaccinations apply the priciple in preventing communicable diseases, notably in the complete eradication of smallpox.
An unexpected trigger for heart attack: Researchers show that dormant bacteria can contribute to atherosclerotic plaques and fatal myocardial infarction, effectively making it an infectious disease.
Scientists developed an AI-based approach to diagnose colorectal cancer from different microbial subgroups in the gut microbiota – a non-invasive and low-cost alternative to colonoscopy screening.
The vaginal microbiome is a largely overlooked area of medicine that could dramatically improve outcomes for common infections, infertility and even cancer for millions of women, a new review finds.
A new, bacteria-based contrast agent illuminates tumors like a neon sign during surgery, enabling more precise resection and reducing the risk of recurrence.
Antibiotics are known for disrupting the microbiome in the gut and thus paving the way for diseases. However, many common non-antibiotics also have this effect, a new study shows.
A new PET imaging technique can accurately detect and monitor Mycobacteroides abscessus lung infections—one of the most difficult-to-diagnose conditions in patients with lung diseases.
Microbiota composition can help prevent pathogenic bacteria from proliferating, known as the barrier effect. Now, scientists have identified seven bacteria involved, paving the way for new therapies.
A University of Liverpool study has used advanced genetic and genomic techniques to offer a major step forward in understanding and diagnosing infectious intestinal diseases.
Finding ways to target antibiotic-resistant bacteria is a scientific and medical priority. A consortium of researchers identified a compound capable of blocking a key protein for virulence, thus “disarming” the pathogenic bacteria.
The incidence of colorectal cancer in young adults has doubled over the last 20 years, with no known reason. Now, a new study links this mysterious trend to childhood exposure to a bacterial toxin.
